JaICA

anti-Crotonaldehyde [CRA], mAb (82D3)

CHF 1'243.00

In stock

JAI-MCA-030N30 µgCHF 1'243.00

More Information
Product Details
Product Type	Monoclonal Antibody
Properties
Clone	82D3
Isotype	Mouse IgG2a
Immunogen/Antigen	CRA-modified keyhole-lympet hemocyanine.
Application	Immunohistochemistry: Recommended concentration is 0.5-1μg/mL on paraffin sections.
Crossreactivity	All Human
Specificity	Recognizes CRA-modified proteins (especially CRA-lysine adducts).
Purity Detail	Protein A purified.
Formulation	Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA.
Isotype Negative Control	Mouse IgG2a Isotype Control
Other Product Data	Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet.
Declaration	Manufactured by JaICA.
Shipping and Handling
Shipping	BLUE ICE
Short Term Storage	+4°C
Long Term Storage	-20°C
Handling Advice	Avoid freeze/thaw cycles.
Use/Stability	Stable for at least 3 years after receipt when stored at -20°C.
Documents
MSDS	Inquire
Product Specification Sheet
Datasheet	Download PDF

Product-specific References

Description

Crotonaldehyde (CRA) is a representative carcinogenic aldehyde formed endogenously through lipid peroxidation. CRA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with CRA and lysine residue leads to the formation of numerous numbers of adducts.

Product References

Endogenous formation of protein adducts with carcinogenic aldehydes: K. Ichihashi, et al.; J. Biol. Chem. 276, 23903 (2001)

Call	+41 61 926 6040
Fax	+41 61 926 6049